Skip to content

The clinical effect of Tuina in the treatment of post-stroke constipation and the brain-gut response mechanism

Study on the clinical effect of Tuina in the treatment of post-stroke constipation and the brain-gut response mechanism based on the "flora-brain-gut" axis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300072480
Enrollment
Unknown
Registered
2023-06-14
Start date
2023-06-19
Completion date
Unknown
Last updated
2023-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-stroke Constipation

Interventions

Trial group: Tuina therapy and life style education of constipation
Control group:Life style education of constipation
Non-constipated group after stroke:None

Sponsors

Yueyang Integrated Traditional Chinese and Western Medicine Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 80 Years

Inclusion criteria

Inclusion criteria: Patients with post-stroke constipation: (1) diagnosed of stroke with duration of stroke>2 weeks, (2) bowel movements met the Rome? criteria for functional constipation, and the constipation occurred after stroke, (3) aged between 60 and 80 years old and no limitation of gender, (4) no defecation-promoting drugs or other constipation-related therapies used in the past 1 week, (5) stable vital signs, clear consciousness and no cognitive impairment, (6) volunteer to participate in the trail and sign the informed consent form. Non-constipated patients after stroke:(1) diagnosed of stroke with duration of stroke>2 weeks, (2) no constipation occurred after stroke, (3) aged between 60 and 80 years old and no limitation of gender, (4) stable vital signs, clear consciousness and no cognitive impairment, (5) volunteer to participate in the trail and sign the informed consent form.

Exclusion criteria

Exclusion criteria: (1)have organic diseases or operation of digestive tract, (2) complicated with severe liver, kidney, heart insufficiency, or abdominal and pelvic malignancy, (3) unable to understand and cooperate with relevant assessment and treatment duo to consciousness disorder, cognitive dysfunction, mental illness or other reasons; (4) constipated before stroke; (5)still participate in other clinical trials 1 week before enrollment.

Design outcomes

Primary

MeasureTime frame
Cleveland Constipation Score;

Secondary

MeasureTime frame
Bristol stool form scale;Zung's self-rating Depression Scale score;Zung's self-rating Anxiety Scale score;Patient-Assessment of Constipation Quality Of Life;Fugl-Meyer motor function assessment;16S rRNA sequencing ;EEG;

Countries

China

Contacts

Public ContactYan Juntao

Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine

doctoryjt@163.com+86 189 3056 1371

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026